Increased 2025 AFFO Guidance $0.06 to $1.30 - $1.32 Per Diluted Share - - Amended, Extended, and Expanded Unsecured Credit Facilities to $440 ...
Gain key insights from Taysha Gene Therapies’ Q3 2025 call: trial milestones, FDA breakthrough, and outlook for TSHA-102.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback